USANA Health Sciences continues its journey as a science-focused health and wellness company, delivering encouraging progress in key areas during the third quarter ended October 3, 2026. The latest results highlight steady advances in customer engagement, operational efficiency, and financial strength while the company expands its omnichannel presence.
Hiya, the children’s health and wellness brand, stood out with an 18% sequential rise in active monthly subscribers, reaching 195,500. The brand added about 29,500 net new subscribers during the quarter. Sales through Target and Amazon more than doubled from the previous quarter, helping Hiya return to year-over-year net sales growth at $32 million. These gains reflect effective investments in customer acquisition and create a solid base for future periods.
The Core Nutritional segment improved its operating margin year-over-year through a leaner cost structure, even with net sales of around $171 million. This efficiency gain shows the benefits of disciplined operations. Sequential customer growth in the Southeast Asia Pacific region further demonstrated that focused initiatives can deliver positive results, supporting the company’s long-term customer engagement goals.
USANA generated $8 million in free cash flow in the third quarter and $36 million year-to-date. The company ended the period with $179 million in cash, zero debt, and inventory reduced by 13% from year-end levels. This financial position provides flexibility to keep investing in product innovation, digital marketing, and channel expansion.
Rise Wellness advanced its retail footprint with the national launch of Protein Pop Balance at Target and online in September. Target sales grew strongly from the second quarter, building on a strengthening retail foundation as the brand works toward more consistent and profitable growth.
The company updated its full-year 2026 guidance to net sales approaching $900 million and Adjusted EBITDA of $77 million. Management expects continued sequential progress at Hiya in both sales and profitability during the fourth quarter. With ongoing investments in science-backed products and broader market reach, USANA is well positioned to build on these foundations heading into 2027.
There are no reviews yet. Be the first one to write one.
